Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo could cut bleeding and recovery time after heart procedure

NCT ID NCT06549842

Disease control Sponsor: Regional Hospital of Scranton Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested two strategies to reduce bleeding and artery blockage after a common heart procedure. 451 patients received either a standard or lower dose of heparin and a different compression band. The goal was to see if the new approach could shorten recovery and lower complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Heparin
What this could lead to
If successful, this approach could shorten recovery time and lower the risk of bleeding and artery blockage after heart catheterization.
What could go wrong
This is a completed trial, but results are not yet published. The lower heparin dose might not prevent clotting as well, and the new band may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

451 people

The number who actually took part.

Started

Aug 2024

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients referred for diagnostic transradial cardiac catheterization 2. Age ≥ 18 years 3. Ability to provide written informed consent Exclusion Criteria: 1. Absence of written informed consent 2. Patients on long-term systemic anticoagulation therapy for a different indication 3. Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason. 4. Patients requiring greater than 6 French catheter access

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial puncture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

arterial occlusion Arterial Occlusive Diseases cardiovascular disorder Hemorrhage hemorrhagic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial puncture Bleeding Cardiovascular diseases Catheter complications Occlusion of artery

Contacts and locations

Locations

  • Apex Heart Institute

    Ahmedabad, Gujarat, 380059, India

  • Regional Hospital of Scranton

    Scranton, Pennsylvania, 18510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.